Literature DB >> 16612082

Role of matrix Gla protein in parathyroid hormone inhibition of osteoblast mineralization.

Rajaram Gopalakrishnan1, Supaporn Suttamanatwong, Ann E Carlson, Renny T Franceschi.   

Abstract

Parathyroid hormone (PTH) exerts biphasic effects on bone, dependent on the frequency and dose of administration. The catabolic actions of PTH on bone have been associated with continuous treatment, an increase in osteoblast-mediated resorption of bone via osteoclast activation, and inhibition of osteoblast activity and mineralization. Downregulation of differentiation markers and inhibition of mineralization by PTH have been reported in primary calvarial explants and osteoblast cell lines. Using MC3T3-E1 osteoblast-like cells, we have shown that matrix Gla protein (MGP) can be induced by PTH, and that this induction may explain the PTH-mediated inhibition of osteoblast biomineralization. MGP is a known inhibitor of mineralization, and mice deficient in Mgp show severe vascular calcification and premature bone mineralization. This review discusses the role of MGP in mineralization, comparing bone and vascular mineralization. In addition to MGP, the regulation and possible role of osteopontin, another known regulator of osteoblast mineralization, in PTH-mediated regulation of bone and vascular mineralization is discussed. 2005 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16612082     DOI: 10.1159/000091378

Source DB:  PubMed          Journal:  Cells Tissues Organs        ISSN: 1422-6405            Impact factor:   2.481


  16 in total

1.  Overexpression of the transcriptional factor Runx2 in osteoblasts abolishes the anabolic effect of parathyroid hormone in vivo.

Authors:  Didier Merciris; Caroline Marty; Corinne Collet; Marie-Christine de Vernejoul; Valerie Geoffroy
Journal:  Am J Pathol       Date:  2007-05       Impact factor: 4.307

Review 2.  The calcium-sensing receptor in bone--mechanistic and therapeutic insights.

Authors:  David Goltzman; Geoffrey N Hendy
Journal:  Nat Rev Endocrinol       Date:  2015-03-10       Impact factor: 43.330

3.  Rad GTPase is essential for the regulation of bone density and bone marrow adipose tissue in mice.

Authors:  Catherine N Withers; Drew M Brown; Innocent Byiringiro; Matthew R Allen; Keith W Condon; Jonathan Satin; Douglas A Andres
Journal:  Bone       Date:  2017-07-18       Impact factor: 4.398

Review 4.  Arterial calcification and bone physiology: role of the bone-vascular axis.

Authors:  Bithika Thompson; Dwight A Towler
Journal:  Nat Rev Endocrinol       Date:  2012-04-03       Impact factor: 43.330

Review 5.  Evidence for FGF23 involvement in a bone-kidney axis regulating bone mineralization and systemic phosphate and vitamin D homeostasis.

Authors:  Aline Martin; L Darryl Quarles
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

6.  Mice Deficient in AKAP13 (BRX) Are Osteoporotic and Have Impaired Osteogenesis.

Authors:  Hisashi Koide; Kenn Holmbeck; Julian C Lui; Xiaoxiao C Guo; Paul Driggers; Tiffany Chu; Ichiro Tatsuno; Caroline Quaglieri; Tomoshige Kino; Jeffrey Baron; Marian F Young; Pamela G Robey; James H Segars
Journal:  J Bone Miner Res       Date:  2015-05-10       Impact factor: 6.741

7.  Knockdown of PTHR1 in osteosarcoma cells decreases invasion and growth and increases tumor differentiation in vivo.

Authors:  P W M Ho; A Goradia; M R Russell; A M Chalk; K M Milley; E K Baker; J A Danks; J L Slavin; M Walia; B Crimeen-Irwin; R A Dickins; T J Martin; C R Walkley
Journal:  Oncogene       Date:  2014-07-21       Impact factor: 9.867

8.  Unexpected Role of Matrix Gla Protein in Osteoclasts: Inhibiting Osteoclast Differentiation and Bone Resorption.

Authors:  Yan Zhang; Liting Zhao; Naining Wang; Jing Li; Fang He; Xu Li; Shufang Wu
Journal:  Mol Cell Biol       Date:  2019-05-28       Impact factor: 4.272

9.  Nuclear fibroblast growth factor 2 (FGF2) isoforms inhibit bone marrow stromal cell mineralization through FGF23/FGFR/MAPK in vitro.

Authors:  Liping Xiao; Alycia Esliger; Marja M Hurley
Journal:  J Bone Miner Res       Date:  2013-01       Impact factor: 6.741

10.  Novel regulators of Fgf23 expression and mineralization in Hyp bone.

Authors:  Shiguang Liu; Wen Tang; Jianwen Fang; Jinyu Ren; Hua Li; Zhousheng Xiao; L D Quarles
Journal:  Mol Endocrinol       Date:  2009-06-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.